Journal for ImmunoTherapy of Cancer (Nov 2021)
745 Oncolytic adenovirus expressing 4-1BBL demonstrates a significant increase of survival in Diffuse Midline Glioma models
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2021)